Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Medical University of South Carolina.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Teresa Kelechi, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT01509599
First received: August 19, 2011
Last updated: January 12, 2012
Last verified: January 2012
  Purpose

Leg vein circulation problems can damage the skin of the lower legs, especially around the ankles, by making it discolored, hard, itchy, red, and swollen. Ulcers often develop. Inflammation is often present in the damaged skin. This study will test whether using a special low compression, cooling, boot-like gel wrap placed around the damaged skin of the lower legs will improve the skin circulation and prevent leg ulcers. The study hypothesis is: A cryotherapy, low-compression cooling gel wrap (CW) plus usual care (UC) (leg elevation, compression stockings) intervention compared to a low compression non-cryotherapy "sham" wrap (NW) plus UC will reduce tissue blood flow (perfusion units) and decrease the incidence of venous leg ulcers (VLUs) during the 9-month study period in individuals with Stage 4 and 5 venous insufficiency.


Condition Intervention Phase
Venous Disease
Venous Vascular Diseases and Syndromes
Venous Insufficiency
Venous Ulcers
Procedure: Cryotherapy: Cooling gel wrap
Procedure: Usual care
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Prevention
Official Title: Preventing Venous Leg Ulcers With Cryotherapy: A Randomized Clinical Trial

Resource links provided by NLM:


Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Skin blood flow [ Time Frame: Skin blood flow will be measured for change at five visits: baseline (visit 1), month 1 (visit 2), month 3 (visit 3), month 6 (visit 4) and 9 (visit 5) ] [ Designated as safety issue: No ]
  • Incidence of venous leg ulcers that develop during the study [ Time Frame: Time point will be assessed at months 1, 3, 6 and 9. If an ulcer develops, participants will be followed weekly, for the duration of the ulcer treatment, up to the end of the study at 9 months. ] [ Designated as safety issue: No ]
    In the event that a venous leg ulcers develops, the volunteer will notify the study personnel within 24 hours. The volunteer will be instructed to return to the primary care/wound care provider for treatment. Study personnel will contact the volunteer each week to assess progress. If the leg ulcers heals during the time enrolled in the study, the volunteer will continue with the intervention.


Secondary Outcome Measures:
  • Quality of life [ Time Frame: During the five measurement points, baseline and then after months, 1, 3, 6, and 9 ] [ Designated as safety issue: No ]
  • Pain [ Time Frame: Measured at baseline, then after months 1, 3, 6, and 9 ] [ Designated as safety issue: No ]
  • Skin temperature [ Time Frame: Will be measured daily by the subject and then by student personnel at baseline, then after months 1, 3, 6, and 9 ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 240
Study Start Date: August 2011
Estimated Study Completion Date: August 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Cryotherapy Procedure: Cryotherapy: Cooling gel wrap
Patients will wear compression stockings (provided), elevate legs on an elevator pillow (provided) and apply the sham cyrotherapy wrap during the home-based intervention
Other Name: Cooling cuff, cool cuff
Sham Comparator: Usual care Procedure: Usual care
Patients will wear compression stockings (provided), elevate legs on an elevator pillow (provided) and apply the sham cyrotherapy wrap (sham) during the home-based intervention
Other Names:
  • Standard of care
  • Guideline guided care

Detailed Description:

This new trial will assess the efficacy of this home-based cryotherapy intervention by adding sequenced tapered cooling after a 30-day intense cooling period. The goal is to reduce skin blood flow of chronically inflamed skin, decrease the incidence of venous leg ulcers and pain, and improve quality of life. A myriad of surgical, pharmacologic, and non-pharmacologic therapies such as compression bandages are often tried, many with limited success. More than 70% of patients with venous disorders such as insufficiency develop edema, skin damage, and ulcers. Ulcer prevention is warranted because of the significant socioeconomic implications in terms of lost workdays and wages, decreased productivity and increased health care costs. Clinicians focus on the multiple treatment approaches, often without consideration of how patients can contribute to their own self-care. Our 9-month intervention is based on principles of heat transfer and cryotherapy theories involving microcirculation. With input from a cryotherapy expert and participants who completed the R21 pilot, the investigators propose a sequenced intervention strategy, where cooling will be dosed daily for 30 minutes for the first month, and then decreased to twice weekly dosing in months 2-3, once weekly in months 4-6, then PRN in months 7-9. The investigators will measure blood flow, skin temperature, pain, quality of life, and the incidence of leg ulcers after months 1, 3, 6 and 9. Eligible participants will be randomized to treatment (low compression cooling wrap) or usual care (low compression non-cooling "sham" wrap). Participants in both groups will receive all study related materials including standardized instruction, skin thermometer, specially designed low compression wraps, leg elevator pillow, and compression stockings, and during an in-depth orientation session. The investigators hypothesize that cryotherapy will enhance the largely ineffective non-pharmacologic self-care usual care model, that is, telling patients to wear compression stockings, elevate the legs, and get more exercise. These strategies are generally inadequate in achieving sustained change. Among our research methods the investigators include rigorous process, impact and outcome monitoring. In an era of expectation for technological and pharmaceutical "fixes", this self-care strategy, if efficacious, could be an economical way to decrease morbidity and pain for thousands of patients, frequently viewed as non-responsive to self care. Prevention of ulcers is also a major potential source of saved medical dollars. This trial is significant due to the burden of venous disorders, the complex physical characteristics of the population including excessive obesity and co-morbidity and the need to reach patients with a feasible, motivational, and supportive strategy to promote self-care. The objective is to establish a new practice standard for prevention.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • aged 21 years or older
  • CEAP Classification: Stage C4 (skin damage) and 5 (healed VLU) - leg ulcer healed within past month with intact epithelium
  • history of healed VLU within past 2 years
  • ankle brachial index (ABI) 0.80 - 1.3 mmHG, absence of peripheral arterial disease
  • intact skin sensation
  • intact thermal sensation
  • agreement to ear compression during waking hours
  • phone, email or mail accessible
  • willingness to make 5 study visits including baseline
  • able to understand protocol by passing test after watching DVD standardized instructions for low literacy
  • able to perform required protocol activities
  • ability to speak English

Exclusion Criteria:

  • diagnosed arterial disease or ABI <0.80 or >1.3 mm Hg (blood flow to the skin is reduced in arterial disease and cooling could cause tissue ischemia)
  • surgical procedures on leg in past 1 year (can affect venous circulation/cause edema)
  • open leg/foot ulcers
  • recent leg infection within past month (increased inflammation)
  • impaired cognitive status (cannot perform procedures)
  • chronic inflammatory and vascular conditions where blood flow of the skin may be impacted such as Lupus erythematosus, lymphedema, Raynaud's, rheumatoid arthritis, scleroderma, end stage renal disease, chronic obstructive pulmonary disease, chronic regional pain syndrome, multiple sclerosis, hypersensitivity to cold, or patients on chemotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01509599

Contacts
Contact: Teresa J Kelechi, PhD, RN 843-792-4602 kelechtj@musc.edu
Contact: Cam M Spencer, BSN, RN 843-792-4771 spencerc@musc.edu

Locations
United States, South Carolina
Medical University of South Carolina Recruiting
Charleston, South Carolina, United States, 29425
Contact: Teresa J Kelechi, PhD, RN    843-792-4602    kelechtj@musc.edu   
Principal Investigator: Teresa J Kelechi, PhD, RN         
Sponsors and Collaborators
Medical University of South Carolina
  More Information

No publications provided

Responsible Party: Teresa Kelechi, Associate Professor and Department Chair, Medical University of South Carolina
ClinicalTrials.gov Identifier: NCT01509599     History of Changes
Other Study ID Numbers: Pro00008711, 1R01NR012237-01A1
Study First Received: August 19, 2011
Last Updated: January 12, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Medical University of South Carolina:
Venous disease
Venous disorders
Venous insufficiency
Venous ulcers
Cryotherapy

Additional relevant MeSH terms:
Leg Ulcer
Ulcer
Varicose Ulcer
Vascular Diseases
Venous Insufficiency
Skin Ulcer
Skin Diseases
Pathologic Processes
Varicose Veins
Cardiovascular Diseases
Methyl salicylate
Antirheumatic Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on August 28, 2014